Where We Are And Where We Are Headed With AI On IBM i

February 16, 2026 Timothy Prickett Morgan

Here we are in 2026, and we have gotten used to GenAI like we did the coronavirus pandemic after it largely ran its course after three years. The difference, of course, is that there is no vaccine for GenAI, especially when a substantial part of the growth in the global economy is coming from enormous capital spending on GenAI hardware and software.

I have spent a large portion of my career as an IT journalist and analyst tracking high end, large scale, distributed computing in its many forms and have been fascinated by the clever and creative advances in the …